CLINICAL_TRIALS
trial_result
· 2015-06-30
Clinical Trial Update: 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia [Phase 2]
Summary
Phase 2 trial of azacitidine (Vidaza) in chronic lymphocytic leukemia was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2015-06-30